-
AstraZeneca delivery delays threatens EU’s Covid vaccination target
Speed Read Fresh setback to bloc’s bid to inoculate 70% of adults by summer
Speed Read -
Coronavirus: age cap in Oxford vaccine trials casts doubt over results
Speed Read AstraZeneca failed to disclose that under-55s made up test group in which jab was most effective
Speed Read -
Coronavirus: inside the ‘ten-month marathon’ to produce Oxford vaccine
In Depth Team behind university’s Covid jab admit the 90% effective dosage was discovered by mistake
In Depth -
Coronavirus: will the Oxford Covid vaccine be the true game-changer?
In Depth Latest trial results show the university’s jab is up to 90% effective
In Depth -
Human trials of Oxford coronavirus vaccine paused over ‘spinal-cord disease fears’
Speed Read Leaked report says volunteer in UK was left unable to walk after receiving two doses
Speed Read -
Oxford scientists: ‘here’s what we are doing to develop our coronavirus vaccine’
In Depth Researchers working to develop the world’s first Covid-19 vaccine explain how it is being done
In Depth -
Reaction: hopes raised in first Oxford vaccine trial - but what happens next?
In Depth Results of first human tests fuel hopes that jab may be rolled out by Christmas
In Depth -
Reaction: Covid vaccine hopes raised by Oxford trial results
In Depth Scientists from university-led team say their jab may offer ‘double defence’ against coronavirus
In Depth -
AstraZeneca rejects 'final' £69bn offer from Pfizer
Speed Read AstraZeneca claims £55-per-share bid undervalues the company and carries a 'big execution risk'
Speed Read -
State must intervene in the fight for AstraZeneca
In Depth Cosseting national champions isn’t the British way. But is it time to make an exception
In Depth
1
2